KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Treasury Shares (2020 - 2025)

Hims & Hers Health's Treasury Shares history spans 6 years, with the latest figure at $13.1 million for Q4 2025.

  • For Q4 2025, Treasury Shares fell 17.02% year-over-year to $13.1 million; the TTM value through Dec 2025 reached $13.1 million, down 17.02%, while the annual FY2025 figure was $13.1 million, 17.02% down from the prior year.
  • Treasury Shares for Q4 2025 was $13.1 million at Hims & Hers Health, down from $14.4 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $20.4 million in Q1 2024 and bottomed at $1.8 million in Q1 2021.
  • The 5-year median for Treasury Shares is $14.5 million (2023), against an average of $12.2 million.
  • The largest annual shift saw Treasury Shares skyrocketed 538.29% in 2022 before it dropped 17.27% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $1.8 million in 2021, then surged by 538.29% to $11.6 million in 2022, then increased by 24.84% to $14.5 million in 2023, then increased by 8.8% to $15.8 million in 2024, then decreased by 17.02% to $13.1 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Treasury Shares are $13.1 million (Q4 2025), $14.4 million (Q3 2025), and $15.9 million (Q2 2025).